Guidelines for the management of castrate-resistant prostate cancer

Por Saad, Fred, Hotte, Sebastien J.
Publicado em 2010

Localized prostate cancer

Por Kapoor, Anil, Hotte, Sebastien J.
Publicado no Can Urol Assoc J (2016)

Chemotherapy research for metastatic prostate cancer

Por Kapoor, Anil, Hotte, Sebastien J.
Publicado no Can Urol Assoc J (2016)

Radionuclides

Por Kapoor, Anil, Hotte, Sebastien J.
Publicado no Can Urol Assoc J (2016)

Androgen receptor axis-targeted agents

Por Kapoor, Anil, Hotte, Sebastien J.
Publicado no Can Urol Assoc J (2016)

Current status of cytokine therapy in management of patients with metastatic renal cell carcinoma

Por Kapoor, Anil K, Hotte, Sébastien J
Publicado em 2007

Systemic therapy for patients with advanced, unresectable ormetastatic renal cell carcinoma: moving to guidelines

Por Hotte, Sébastien J, Kapoor, Anil K
Publicado em 2007

Treatment of adult rhabdoid renal cell carcinoma with sorafenib

Por Kapoor, Anil, Tutino, Robert, Kanaroglou, Androniki, Hotte, Sebastien J.
Publicado em 2008

Cytokines and cell adhesion molecules exhibit distinct profiles in health, ovarian cancer, and breast cancer

Por Henderson, Matthew P.A., Hirte, Holger, Hotte, Sebastien J., Kavsak, Peter A.
Publicado no Heliyon (2016)

High-Dose Chemotherapy Followed by Peripheral and/or Bone Marrow Stem Cell Transplant in Patients With Advanced Sarcoma: Experience of a Canadian Centre

Por Hotte, Sébastien J., Smith, Anne M., Bramwell, Vivien H.C., Howson-Jan, Kang
Publicado em 2004

The 2015 CUA-CUOG Guidelines for the management of castration-resistant prostate cancer (CRPC)

Por Saad, Fred, Chi, Kim N., Finelli, Antonio, Hotte, Sebastien J., Izawa, Jonathan, Kapoor, Anil, Kassouf, Wassim, Loblaw, Andrew, North, Scott, Rendon, Ricardo, So, Alan, Usmani, Nawaid, Vigneault, Eric, Fleshner, Neil E.
Publicado no Can Urol Assoc J (2015)

Evaluation of second-line and subsequent targeted therapies in metastatic renal cell cancer (mRCC) patients treated with first-line cediranib

Por Richter, Suzanne, Seah, Jo-An, Pond, Gregory R., Gan, Hui K., Mackenzie, Mary J., Hotte, Sebastien J., Mukherjee, Som D., Murray, Nevin, Kollmannsberger, Christian, Heng, Daniel, Haider, Masoom A., Halford, Robert, Ivy, S. Percy, Moore, Malcolm J., Sridhar, Srikala. S.
Publicado no Can Urol Assoc J (2014)

A randomized phase II study of cediranib alone versus cediranib in combination with dasatinib in docetaxel resistant, castration resistant prostate cancer patients

Por Spreafico, Anna, Chi, Kim N., Sridhar, Srikala S., Smith, David C., Carducci, Michael A., Kavsak, Peter, Wong, Tracy S., Wang, Lisa, Ivy, S. Percy, Mukherjee, Som Dave, Kollmannsberger, Christian K., Sukhai, Mahadeo A., Takebe, Naoko, Kamel-Reid, Suzanne, Siu, Lillian L., Hotte, Sebastien J.
Publicado no Invest New Drugs (2014)

Phase I study of decitabine in combination with vorinostat in patients with advanced solid tumors and non-Hodgkin's lymphomas

Por Stathis, Anastasios, Hotte, Sebastien J., Chen, Eric X., Hirte, Holger W., Oza, Amit M., Moretto, Patricia, Webster, Sheila, Laughlin, Anne, Stayner, Lee-Anne, McGill, Shauna, Wang, Lisa, Zhang, Wen-jiang, Espinoza-Delgado, Igor, Holleran, Julianne L., Egorin, Merrill J., Siu, Lillian L.
Publicado em 2009

A phase I trial of ANG1/2-Tie2 inhibitor trebaninib (AMG386) and temsirolimus in advanced solid tumors (PJC008/NCI♯9041)

Por Chiu, Joanne W., Hotte, Sebastien J., Kollmannsberger, Christian K., Renouf, Daniel J., Cescon, David W., Hedley, David, Chow, Sue, Moscow, Jeffrey, Chen, Zhuo, Perry, Meghan, Diaz-Padilla, Ivan, Tan, David, Hirte, Hal, McWhirter, Elaine, Chen, Helen, Siu, Lillian L., Bedard, Philippe L.
Publicado no Invest New Drugs (2015)

A phase Ib combination study of RO4929097, a gamma-secretase inhibitor, and temsirolimus in patients with advanced solid tumors

Por Diaz-Padilla, Ivan, Hirte, Hal, Oza, Amit M., Clarke, Blaise A., Cohen, Brenda, Reedjik, Michael, Zhang, Tong, Kamel-Reid, Suzanne, Ivy, S. Percy, Hotte, Sebastien J., Razak, Albiruni A. R., Chen, Eric X., Brana, Irene, Wizemann, Monika, Wang, Lisa, Siu, Lillian L., Bedard, Philippe L.
Publicado em 2013

A phase I study of the oral gamma secretase inhibitor R04929097 in combination with gemcitabine in patients with advanced solid tumors (PHL-078/CTEP 8575)

Por Richter, Suzanne, Bedard, Philippe L., Chen, Eric Xueyu, Clarke, Blaise A., Tran, Ben, Hotte, Sebastien J., Stathis, Anastasios, Hirte, Hal W., Razak, Albiruni R. A., Reedijk, Michael, Chen, Zhuo, Cohen, Brenda, Zhang, Wen-Jiang, Wang, Lisa, Ivy, S. Percy, Moore, Malcolm J., Oza, Amit M., Siu, Lillian L., McWhirter, Elaine
Publicado em 2013